Could a diabetes drug help heal the gut in short bowel syndrome?
NCT ID NCT07297238
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This study tests whether a GLP-1 drug (semaglutide) can improve intestinal barrier function in people with short bowel syndrome and intestinal failure. Twenty adults will receive either the drug or a placebo for 28 days, alongside standard care. Researchers will measure blood markers of gut health and nutrient absorption.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinling Hospital
RECRUITINGNanjing, China, 210002, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jinling Hospital
RECRUITINGNanning, China, 210002, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.